Stevanato Group S.p.A.

STVN

IT0005452658

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 12:06:40 2024-05-17 pm EDT			5-day change	1st Jan Change
20.5 ^USD	-1.94%		-6.05%	-24.88%

May. 15	Transcript : Stevanato Group S.p.A. Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM
May. 13	Morgan Stanley Lowers Price Target on Stevanato Group to $26 From $30, Keeps Equalweight Rating	MT

Stevanato Group S.P.A. Provides Revenue Guidance for the Full Year 2022

November 08, 2022 at 06:30 am EST

Stevanato Group S.p.A. provided revenue guidance for the full year 2022. For the year, the company expected revenue in the range of €961 million to €971 million.

Latest news about Stevanato Group S.p.A.

Transcript : Stevanato Group S.p.A. Presents at Bank of America Health Care Conference 2024, May-15-2024 11:20 AM	May. 15
Morgan Stanley Lowers Price Target on Stevanato Group to $26 From $30, Keeps Equalweight Rating	May. 13	MT
UBS Adjusts Stevanato Price Target to $24 From $34, Maintains Neutral Rating	May. 10	MT
Sector Update: Health Care Stocks Higher Late Afternoon	May. 09	MT
Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading	May. 09	MT
Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut; Shares Fall 22%	May. 09	MT
Sector Update: Health Care Stocks Steady Pre-Bell Thursday	May. 09	MT
Sector Update: Health Care	May. 09	MT
Transcript : Stevanato Group S.p.A., Q1 2024 Earnings Call, May 09, 2024	May. 09
Stevanato's Q1 Adjusted Earnings, Revenue Fall; 2024 Guidance Cut	May. 09	MT
Stevanato Group S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Stevanato Group S.P.A. Provides Revenue Guidance for 2024	May. 09	CI
BNP Paribas Exane Initiates Stevanato Group With Outperform Rating	Apr. 22	MT
Stevanato Group Names Ugo Gay as Chief Operations Officer	Apr. 04	MT
Stevanato Group S.p.A. Announces the Appointment of Ugo Gay as Chief Operations Officer	Apr. 04	CI
Stevanato Group Closes $379.7 Million Public Share Offering	Mar. 27	MT
Stevanato Group Prices Upsized $330 Million Public Share Offering; Shares Rise	Mar. 22	MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday	Mar. 22	MT
Stevanato Group Prices Upsized $330 Million Public Share Offering	Mar. 22	MT
Sector Update: Health Care Stocks Gain Pre-Bell Thursday	Mar. 21	MT
Stevanato Group Launches Primary, Secondary Offerings; Shares Drop After Hours	Mar. 20	MT
UBS Raises Stevanato Price Target to $34 From $31, Maintains Neutral Rating	Mar. 08	MT
Stevanato Group Q4 Adjusted Earnings Declines, Revenue Rises; Shares Fall	Mar. 07	MT
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	Mar. 07	MT
Sector Update: Health Care	Mar. 07	MT

Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-14 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Stevanato Group S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

20.91 USD

Average target price

29.16 USD

Spread / Average Target

+39.45%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
STEVANATO GROUP S.P.A.	-24.88%	5.72B
ABBOTT LABORATORIES	-5.46%	182B
MEDTRONIC PLC	+3.47%	114B
BECTON, DICKINSON AND COMPANY	-3.32%	68.38B
DEXCOM, INC.	+6.07%	52.46B
CENCORA, INC.	+7.96%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.05%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	-0.47%	25.79B

Other Medical Equipment, Supplies & Distribution